Wolverine Trading, LLC Rocket Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$20.66 - $26.72 $66,112 - $85,504
3,200 Added 30.77%
13,600 $292,000
Q1 2024

May 15, 2024
SELL
$26.16 - $30.74 $102,024 - $119,886
-3,900 Reduced 27.27%
10,400 $280,000
Q4 2023

Feb 14, 2024
SELL
$16.78 - $31.94 $78,866 - $150,118
-4,700 Reduced 24.74%
14,300 $428,000
Q3 2023

Nov 15, 2023
BUY
$15.07 - $24.05 $286,330 - $456,950
19,000 New
19,000 $389,000
Q1 2021

May 14, 2021
BUY
$43.34 - $65.91 $221,034 - $336,141
5,100 New
5,100 $221,000

Others Institutions Holding RCKT

# of Institutions
209
Shares Held
93.2M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $890M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email